The Role of TAM Family Receptors in Immune Cell Function: Implications for Cancer Therapy

Magdalena Paolino1, Josef M Penninger2

  • 1IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Dr. Bohrgasse 3, A-1030 Vienna, Austria. magdalena.paolino@imba.oeaw.ac.at.

Cancers
|October 25, 2016
PubMed

Insights

TAM receptors (Tyro3, Axl, Mer) regulate immune homeostasis and tissue repair. Their dysregulation links to diseases, and their modulation offers potential cancer immunotherapy strategies.

Area of Science:

  • Immunology
  • Molecular Biology
  • Oncology

Background:

  • The TAM receptor tyrosine kinases (Tyro3, Axl, Mer) are crucial for immune homeostasis, guided by ligands Gas6 and Pros1.
  • These receptors resolve inflammation by suppressing innate cell activation, promoting tissue repair, and clearing apoptotic cells.
  • Dysregulated TAM signaling is implicated in autoimmune, inflammatory, infectious diseases, and cancer pathogenesis.

Approach:

  • This review synthesitsizes current knowledge on TAM receptor functions in immunity.
  • It specifically examines their role in regulating anti-tumor immune responses.
  • The implications for cancer immunotherapy strategies are discussed.

Key Points:

  • TAM receptors act as negative immune regulators, essential for maintaining tissue homeostasis.
  • They play a dual role in cancer, influencing tumor development and anti-tumor immunity.
  • Targeting TAM receptors presents a promising avenue for novel cancer therapies.

Conclusions:

  • Understanding TAM receptor signaling is vital for comprehending immune regulation and disease pathogenesis.
  • Their complex role in cancer necessitates further investigation for effective therapeutic targeting.
  • Modulating TAM receptors holds significant potential for advancing cancer immunotherapy.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K